A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
Clinical trial NCT05736835 · COMPLETED
Trial details
- NCT number
- NCT05736835
- Sponsor
- CyanVac LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2025-12-16
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.